Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients
Background: Parenteral lipid emulsions in critical care are traditionally based on soybean oil (SO) and rich in pro-inflammatory omega-6 fatty acids (FAs). Parenteral nutrition (PN) strategies with the aim of reducing omega-6 FAs may potentially decrease the morbidity and mortality in critically ill...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
BioMed Central
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/33474/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.33474 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.334742022-08-01T02:52:45Z http://eprints.um.edu.my/33474/ Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients Notz, Quirin Lee, Zheng-Yii Menger, Johannes Elke, Gunnar Hill, Aileen Kranke, Peter Roeder, Daniel Lotz, Christopher Meybohm, Patrick Heyland, Daren K. Stoppe, Christian R Medicine RC Internal medicine Background: Parenteral lipid emulsions in critical care are traditionally based on soybean oil (SO) and rich in pro-inflammatory omega-6 fatty acids (FAs). Parenteral nutrition (PN) strategies with the aim of reducing omega-6 FAs may potentially decrease the morbidity and mortality in critically ill patients. Methods: A systematic search of MEDLINE, EMBASE, CINAHL and CENTRAL was conducted to identify all randomized controlled trials in critically ill patients published from inception to June 2021, which investigated clinical omega-6 sparing effects. Two independent reviewers extracted bias risk, treatment details, patient characteristics and clinical outcomes. Random effect meta-analysis was performed. Results: 1054 studies were identified in our electronic search, 136 trials were assessed for eligibility and 26 trials with 1733 critically ill patients were included. The median methodologic score was 9 out of 14 points (95% confidence interval CI] 7, 10). Omega-6 FA sparing PN in comparison with traditional lipid emulsions did not decrease overall mortality (20 studies; risk ratio RR] 0.91; 95% CI 0.76, 1.10; p= 0.34) but hospital length of stay was substantially reduced (6 studies; weighted mean difference WMD] - 6.88; 95% CI - 11.27, - 2.49; p= 0.002). Among the different lipid emulsions, fish oil (FO) containing PN reduced the length of intensive care (8 studies; WMD -3.53; 95% CI - 6.16, - 0.90; p= 0.009) and rate of infectious complications (4 studies; RR 0.65; 95% CI 0.44, 0.95; p= 0.03). When FO was administered as a stand-alone medication outside PN, potential mortality benefits were observed compared to standard care. Conclusion: Overall, these findings highlight distinctive omega-6 sparing effects attributed to PN. Among the different lipid emulsions, FO in combination with PN or as a stand-alone treatment may have the greatest clinical impact. BioMed Central 2022-01-19 Article PeerReviewed Notz, Quirin and Lee, Zheng-Yii and Menger, Johannes and Elke, Gunnar and Hill, Aileen and Kranke, Peter and Roeder, Daniel and Lotz, Christopher and Meybohm, Patrick and Heyland, Daren K. and Stoppe, Christian (2022) Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients. Critical Care, 26 (1). ISSN 1364-8535, DOI https://doi.org/10.1186/s13054-022-03896-3 <https://doi.org/10.1186/s13054-022-03896-3>. (In Press) 10.1186/s13054-022-03896-3 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine RC Internal medicine |
spellingShingle |
R Medicine RC Internal medicine Notz, Quirin Lee, Zheng-Yii Menger, Johannes Elke, Gunnar Hill, Aileen Kranke, Peter Roeder, Daniel Lotz, Christopher Meybohm, Patrick Heyland, Daren K. Stoppe, Christian Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
description |
Background: Parenteral lipid emulsions in critical care are traditionally based on soybean oil (SO) and rich in pro-inflammatory omega-6 fatty acids (FAs). Parenteral nutrition (PN) strategies with the aim of reducing omega-6 FAs may potentially decrease the morbidity and mortality in critically ill patients. Methods: A systematic search of MEDLINE, EMBASE, CINAHL and CENTRAL was conducted to identify all randomized controlled trials in critically ill patients published from inception to June 2021, which investigated clinical omega-6 sparing effects. Two independent reviewers extracted bias risk, treatment details, patient characteristics and clinical outcomes. Random effect meta-analysis was performed. Results: 1054 studies were identified in our electronic search, 136 trials were assessed for eligibility and 26 trials with 1733 critically ill patients were included. The median methodologic score was 9 out of 14 points (95% confidence interval CI] 7, 10). Omega-6 FA sparing PN in comparison with traditional lipid emulsions did not decrease overall mortality (20 studies; risk ratio RR] 0.91; 95% CI 0.76, 1.10; p= 0.34) but hospital length of stay was substantially reduced (6 studies; weighted mean difference WMD] - 6.88; 95% CI - 11.27, - 2.49; p= 0.002). Among the different lipid emulsions, fish oil (FO) containing PN reduced the length of intensive care (8 studies; WMD -3.53; 95% CI - 6.16, - 0.90; p= 0.009) and rate of infectious complications (4 studies; RR 0.65; 95% CI 0.44, 0.95; p= 0.03). When FO was administered as a stand-alone medication outside PN, potential mortality benefits were observed compared to standard care. Conclusion: Overall, these findings highlight distinctive omega-6 sparing effects attributed to PN. Among the different lipid emulsions, FO in combination with PN or as a stand-alone treatment may have the greatest clinical impact. |
format |
Article |
author |
Notz, Quirin Lee, Zheng-Yii Menger, Johannes Elke, Gunnar Hill, Aileen Kranke, Peter Roeder, Daniel Lotz, Christopher Meybohm, Patrick Heyland, Daren K. Stoppe, Christian |
author_facet |
Notz, Quirin Lee, Zheng-Yii Menger, Johannes Elke, Gunnar Hill, Aileen Kranke, Peter Roeder, Daniel Lotz, Christopher Meybohm, Patrick Heyland, Daren K. Stoppe, Christian |
author_sort |
Notz, Quirin |
title |
Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
title_short |
Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
title_full |
Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
title_fullStr |
Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
title_full_unstemmed |
Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
title_sort |
omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients |
publisher |
BioMed Central |
publishDate |
2022 |
url |
http://eprints.um.edu.my/33474/ |
_version_ |
1740826033777541120 |
score |
13.211869 |